Abstract

ABSTRACT The two leading yeast pathogens of humans, Candida albicans and Cryptococcus neoformans, cause systemic infections in >1.4 million patients worldwide with mortality rates approaching 75%. It is thus imperative to study fungal virulence mechanisms, efficacy of antifungal drugs, and host response pathways. While this is commonly done in mammalian models, which are afflicted by ethical and practical concerns, invertebrate models, such as wax moth larvae and nematodes have been introduced over the last two decades. To complement existing invertebrate host models, we developed fifth instar caterpillars of the Tobacco Hornworm moth Manduca sexta as a novel host model. These caterpillars can be maintained at 37°C, are suitable for injections with defined amounts of yeast cells, and are susceptible to the most threatening yeast pathogens, including C. albicans, C. neoformans, C. auris, and C. glabrata. Importantly, fungal burden can be assessed daily throughout the course of infection in a single caterpillar’s feces and hemolymph. Infected caterpillars can be rescued by treatment with antifungal drugs. Notably, these animals are large enough for weight to provide a reliable and reproducible measure of fungal disease and to facilitate host tissue-specific expression analyses. M. sexta caterpillars combine a suite of parameters that make them suitable for the study of fungal virulence.

Highlights

  • Fungal infections pose a serious threat to human health and well-being worldwide

  • M. sexta caterpillars are susceptible to the leading fungal pathogen C. albicans at 37°C

  • We first aimed to determine if M. sexta fifth instar caterpillars (Figure 1(a)), reared and maintained at standard conditions, are susceptible to C. albicans

Read more

Summary

Introduction

Fungal infections pose a serious threat to human health and well-being worldwide. Cryptococcosis incidence rates are on the decline in North America, cryptococcosis as an AIDS-defining illness is responsible for 15% of all AIDS-related deaths worldwide [3,4]. This dire situation is further con­ founded by the emergence of drug-resistant yeast spe­ cies, such as C. glabrata and C. auris. C. glabrata, the most common non-albicans Candida species associated with nosocomial blood stream infections [6], is intrin­ sically less susceptible to azole drugs and acquires resis­ tance to echinocandins rapidly [7].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call